Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry

Autor: Marc A. Brouwer, Ron Pisters, Martin E.W. Hemels, Harry J.G.M. Crijns, P. A. G. Zwart, W. L. ten Holt, S. P. G. van Vugt, Paulus Kirchhof, Arif Elvan

Publikováno v: Netherlands Heart Journal, 25, 551-558
Netherlands Heart Journal, 25(10), 551-558. Bohn Stafleu van Loghum
Netherlands Heart Journal, 25, 10, pp. 551-558
Netherlands Heart Journal

Background The Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry investigated the safety and efficacy of the factor Xa inhibitor rivaroxaban. We studied the Dutch XANTUS cohort to a ssess drug safety and prescrip

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a8e60836bc59705cee827703eac538c
http://hdl.handle.net/2066/179607

[Severe hyponatremia, possibly due to inappropriate antidiuretic hormone secretion, during use of the antidepressant fluoxetine]

Autor: W L, ten Holt, C H, Klaassen, G, Schrijver

Publikováno v: Nederlands tijdschrift voor geneeskunde. 138(23)

In a 78-year-old female with hyponatraemia, the syndrome of inappropriate ADH secretion as a side effect of fluoxetine, a relatively new antidepressive drug, was tentatively diagnosed. In the literature 14 cases of this adverse reaction have been des

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::00339c0b66284d593e4f62a94b518328
https://pubmed.ncbi.nlm.nih.gov/7935930